Company
Luckwel Pharmaceuticals, Inc.
Headquarters: Cambridge, MA, United States
Employees: 1
CEO: Mr. Kingrich J. Lee
Market Cap
$515.1 Million
USD as of July 1, 2022
Luckwel Pharmaceuticals, Inc. Categories
United States Financials Shell CompaniesUnited States Financials United States Shell Companies
Top Competitors by Market Capitalization
Industry: Shell Companies
Sector:
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $887.16 B |
| JPMorgan | $599.29 B |
| Visa | $550.38 B |
| Mastercard | $416.63 B |
| Bank of America | $316.02 B |
Detailed Description
Luckwel Pharmaceuticals Inc. does not have significant operations. It focuses to acquire, develop, manufacture, and market pharmaceutical medications. The company was formerly known as Luckycom Pharmaceuticals Inc. and changed its name to Luckwel Pharmaceuticals Inc. in April 2018. Luckwel Pharmaceuticals Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Luckwel Pharmaceuticals, Inc. has the following listings and related stock indices.
Stock: OTC: LWEL wb_incandescent